This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Universitè Catholique De Louvain. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Stéphanie Lienart: Innovator in Anti-GARP Antibodies
Introduction
Stéphanie Lienart is a notable inventor based in Wezembeek-Oppem, Belgium. He has made significant contributions to the field of immunology, particularly in the development of methods for screening anti-GARP antibodies. His work has implications for understanding immune responses and potential therapeutic applications.
Latest Patents
Stéphanie Lienart holds a patent for a "Method of screening for anti-GARP antibodies." This invention relates to a protein that binds to GARP in the presence of TGF-β and outlines various uses for this binding in medical research and treatment.
Career Highlights
Throughout his career, Lienart has worked with prestigious institutions, including Université Catholique De Louvain and Argenx Bvba. His experience in these organizations has allowed him to collaborate on innovative projects that advance scientific knowledge in his field.
Collaborations
Stéphanie has collaborated with esteemed colleagues such as Sophie Lucas and Pierre G Coulie. These partnerships have contributed to the success of his research and the development of his patented methods.
Conclusion
Stéphanie Lienart is a distinguished inventor whose work on anti-GARP antibodies showcases his expertise and dedication to advancing immunological research. His contributions are valuable to the scientific community and have the potential to impact therapeutic strategies in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile